The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 29, 2025
Filed:
Jan. 10, 2020
Applicant:
Transthera Sciences (Nanjing), Inc., Jiangsu, CN;
Inventors:
Assignee:
TransThera Sciences (Nanjing), Inc., Jiangsu, CN;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/4025 (2006.01); A61K 31/4155 (2006.01); A61K 31/437 (2006.01); A61K 31/5377 (2006.01); C07D 207/34 (2006.01); C07D 209/14 (2006.01); C07D 231/14 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/4025 (2013.01); A61K 31/4155 (2013.01); A61K 31/437 (2013.01); A61K 31/5377 (2013.01); C07D 207/34 (2013.01); C07D 209/14 (2013.01); C07D 231/14 (2013.01); C07D 401/06 (2013.01); C07D 403/06 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention relates to the technical field of pharmaceuticals. Specifically, the present invention relates to a halo-allylamine compound, or a pharmaceutically acceptable salt, an ester, a stereoisomer or a tautomer thereof, and a pharmaceutical formulation and a pharmaceutical composition comprising the compounds, and use in preventing and/or treating a disease related to or mediated by the SSAO/VAP-1 protein, wherein R, R, R, R, R, R, Land Cyare defined in the specification.